참고문헌
- Aszodi A, Legate KR, Nakchbandi I and Fassler R (2006) What mouse mutants teach us about extracellular matrix function. Annu Rev Cell Dev Biol 22, 591-621 https://doi.org/10.1146/annurev.cellbio.22.010305.104258
- Bornstein P and Sage EH (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14, 608-616 https://doi.org/10.1016/S0955-0674(02)00361-7
- Jun JI and Lau LF (2011) Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10, 945-963 https://doi.org/10.1038/nrd3599
- Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M., Crochet J and Perbal B (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12, 10-21 https://doi.org/10.1128/MCB.12.1.10
- O'Brien TP, Yang GP, Sanders L and Lau LF (1990) Expression of cyr61, a growth factor-inducible immediateearly gene. Mol Cell Biol 10, 3569-3577 https://doi.org/10.1128/MCB.10.7.3569
- Bradham DM, Igarashi A, Potter RL and Grotendorst GR (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114, 1285-1294 https://doi.org/10.1083/jcb.114.6.1285
- Holbourn KP, Acharya KR and Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33, 461-473 https://doi.org/10.1016/j.tibs.2008.07.006
- Leask A and Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119, 4803-4810 https://doi.org/10.1242/jcs.03270
- Perbal BV and Takigawa M (2005) CCN proteins : a new family of cell growth and differentiation regulators. Imperial College Press, London ; Hackensack, NJ
- Fukunaga-Kalabis M, Martinez G, Liu ZJ et al (2006) CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. J Cell Biol 175, 563-569 https://doi.org/10.1083/jcb.200602132
- Chen CC, Chen N and Lau LF (2001) The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276, 10443-10452 https://doi.org/10.1074/jbc.M008087200
- Grzeszkiewicz TM, Kirschling DJ, Chen N and Lau LF (2001) CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem 276, 21943-21950 https://doi.org/10.1074/jbc.M100978200
- Gao R and Brigstock DR (2006) A novel integrin alpha5beta1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells. Gut 55, 856-862 https://doi.org/10.1136/gut.2005.079178
- Babic AM, Chen CC and Lau LF (1999) Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19, 2958-2966 https://doi.org/10.1128/MCB.19.4.2958
- Soon LL, Yie TA, Shvarts A, Levine AJ, Su F and Tchou-Wong KM (2003) Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem 278, 11465-11470 https://doi.org/10.1074/jbc.M210945200
- Lake AC, Bialik A, Walsh K and Castellot JJ Jr (2003) CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility. Am J Pathol 162, 219-231 https://doi.org/10.1016/S0002-9440(10)63813-8
- Lau LF and Lam SC (1999) The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248, 44-57 https://doi.org/10.1006/excr.1999.4456
- Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54, 57-79 https://doi.org/10.1136/mp.54.2.57
- Fan WH, Pech M and Karnovsky MJ (2000) Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 79, 915-923 https://doi.org/10.1078/0171-9335-00122
- Grzeszkiewicz TM, Lindner V, Chen N, Lam SC and Lau LF (2002) The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 143, 1441-1450 https://doi.org/10.1210/endo.143.4.8731
- Shimoyama T, Hiraoka S, Takemoto M et al (2010) CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler Thromb Vasc Biol 30, 675-682 https://doi.org/10.1161/ATVBAHA.110.203356
- Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T and Takigawa M (2001) CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268, 6058-6065 https://doi.org/10.1046/j.0014-2956.2001.02553.x
- Zuo GW, Kohls CD, He BC et al (2010) The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol 25, 795-806
- Parisi MS, Gazzerro E, Rydziel S and Canalis E (2006) Expression and regulation of CCN genes in murine osteoblasts. Bone 38, 671-677 https://doi.org/10.1016/j.bone.2005.10.005
- Maeda A, Nishida T, Aoyama E et al (2009) CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem 145, 207-216
- Ono M, Inkson CA, Kilts TM and Young MF (2011) WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J Bone Miner Res 26, 193-208 https://doi.org/10.1002/jbmr.205
- Kubota S and Takigawa M (2007) CCN family proteins and angiogenesis: from embryo to adulthood. Angiogenesis 10, 1-11 https://doi.org/10.1007/s10456-006-9058-5
- Babic AM, Kireeva ML, Kolesnikova TV and Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 95, 6355-6360 https://doi.org/10.1073/pnas.95.11.6355
- Lin CG, Leu SJ, Chen N et al (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278, 24200-24208 https://doi.org/10.1074/jbc.M302028200
- Shimo T, Nakanishi T, Nishida T et al (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 126, 137-145 https://doi.org/10.1093/oxfordjournals.jbchem.a022414
- Fataccioli V, Abergel V, Wingertsmann L et al (2002) Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate. Hum Gene Ther 13, 1461-1470 https://doi.org/10.1089/10430340260185094
- Inoki I, Shiomi T, Hashimoto G et al (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16, 219-221 https://doi.org/10.1096/fj.01-0332fje
- Nathans D, Lau LF, Christy B, Hartzell S, Nakabeppu Y and Ryder K (1988) Genomic response to growth factors. Cold Spring Harb Symp Quant Biol 53 Pt 2, 893-900 https://doi.org/10.1101/SQB.1988.053.01.102
- Grotendorst GR (1997) Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8, 171-179 https://doi.org/10.1016/S1359-6101(97)00010-5
- Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM and Lau LF (2005) Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem 280, 8229-8237 https://doi.org/10.1074/jbc.M404903200
- Dhar A and Ray A (2010) The CCN family proteins in carcinogenesis. Exp Oncol 32, 2-9
- Perbal B (2001) The CCN family of genes: a brief history. Mol Pathol 54, 103-104 https://doi.org/10.1136/mp.54.2.103
- Bleau AM, Planque N and Perbal B (2005) CCN proteins and cancer: two to tango. Front Biosci 10, 998-1009 https://doi.org/10.2741/1594
- Perbal B (2006) NOV story: the way to CCN3. Cell Commun Signal 4, 3 https://doi.org/10.1186/1478-811X-4-3
- Gery S, Xie D, Yin D et al (2005) Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 11, 7243-7254 https://doi.org/10.1158/1078-0432.CCR-05-0231
- Lv H, Fan E, Sun S et al(2009) Cyr61 is up-regulated in prostate cancer and associated with the p53 gene status. J Cell Biochem 106, 738-744 https://doi.org/10.1002/jcb.22075
- Watari H, Xiong Y, Hassan MK and Sakuragi N (2009) Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype. Gynecol Oncol 112, 229-234 https://doi.org/10.1016/j.ygyno.2008.09.039
- Planque N and Perbal B (2003) A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int 3, 15 https://doi.org/10.1186/1475-2867-3-15
- Schmitz P, Gerber U, Jungel E, Schutze N, Blaheta R and Bendas G (2013) Cyr61/CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro. Int J Clin Pharmacol Ther 51, 47-50 https://doi.org/10.5414/CPP51047
- Tsai MS, Hornby AE, Lakins J and Lupu R (2000) Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res 60, 5603-5607
- Xie D, Yin D, Tong X et al (2004) Cyr61 is overexpressed in gliomas and involved in integrin-linked kinasemediated Akt and beta-catenin- TCF/Lef signaling pathways. Cancer Res 64, 1987-1996 https://doi.org/10.1158/0008-5472.CAN-03-0666
- Chen PP, Li WJ, Wang Y et al (2007) Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One 2, e534 https://doi.org/10.1371/journal.pone.0000534
- Maeta N, Osaki M, Shomori K et al (2007) CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma. Oncology 73, 118-126 https://doi.org/10.1159/000121000
- Chien W, Kumagai T, Miller CW et al (2004) Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279, 53087-53096 https://doi.org/10.1074/jbc.M410254200
- Croci S, Landuzzi L, Nicoletti G et al (2007) Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. Pathol Oncol Res 13, 336-339 https://doi.org/10.1007/BF02940313
- Deng YZ, Chen PP, Wang Y et al(2007) Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J Biol Chem 282, 36571-36581 https://doi.org/10.1074/jbc.M704141200
- Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K and Mansel RE (2004) Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11, 781-791 https://doi.org/10.1677/erc.1.00825
- Bennewith KL, Huang X, Ham CM et al (2009) The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 69, 775-784 https://doi.org/10.1158/0008-5472.CAN-08-0987
- Shakunaga T, Ozaki T, Ohara N et al (2000) Expression of connective tissue growth factor in cartilaginous tumors. Cancer 89, 1466-1473 https://doi.org/10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G
- Chien W, O'Kelly J, Lu D et al (2011) Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol 38, 1741-1747
- Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549 https://doi.org/10.1016/S1535-6108(03)00132-6
- Shimo T, Kubota S, Yoshioka N et al (2006) Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res 21, 1045-1059 https://doi.org/10.1359/jbmr.060416
- Bleau AM, Planque N, Lazar N et al (2007) Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation. J Cell Biochem 101, 1475-1491 https://doi.org/10.1002/jcb.21262
- Gupta N, Wang H, McLeod TL et al (2001) Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54, 293-299 https://doi.org/10.1136/mp.54.5.293
- Gellhaus A, Dong X, Propson S et al (2004) Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279, 36931-36942 https://doi.org/10.1074/jbc.M404073200
- Benini S, Perbal B, Zambelli D et al (2005) In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24, 4349-4361 https://doi.org/10.1038/sj.onc.1208620
- Fukunaga-Kalabis M, Martinez G, Telson SM et al (2008) Downregulation of CCN3 expression as a potential mechanism for melanoma progression. Oncogene 27, 2552-2560 https://doi.org/10.1038/sj.onc.1210896
- Maillard M, Cadot B, Ball RY et al (2001) Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol 54, 275-280 https://doi.org/10.1136/mp.54.4.275
- Manara MC, Perbal B, Benini S et al (2002) The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol 160, 849-859 https://doi.org/10.1016/S0002-9440(10)64908-5
- Glukhova L, Angevin E, Lavialle C et al (2001) Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet 130, 105-110 https://doi.org/10.1016/S0165-4608(01)00477-0
- Zhang T, Zhao C, Luo L et al (2013) The clinical and prognostic significance of CCN3 expression in patients with cervical cancer. Adv Clin Exp Med 22, 839-845
- Pennica D, Swanson TA, Welsh JW et al (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A 95, 14717-14722 https://doi.org/10.1073/pnas.95.25.14717
- Davies SR, Davies ML, Sanders A, Parr C, Torkington J and Jiang WG (2010) Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. Int J Oncol 36, 1129-1136
- Xie D, Nakachi K, Wang H, Elashoff R and Koeffler HP (2001) Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61, 8917-8923
- Chuang JY, Chang AC, Chiang IP, Tsai MH and Tang CH (2013) Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells. PLoS One 8, e78022 https://doi.org/10.1371/journal.pone.0078022
- Hashimoto Y, Shindo-Okada N, Tani M, Takeuchi K, Toma H and Yokota J (1996) Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res 56, 5266-5271
- Hashimoto Y, Shindo-Okada N, Tani M et al (1998) Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells. J Exp Med 187, 289-296 https://doi.org/10.1084/jem.187.3.289
- Davies SR, Watkins G, Mansel RE and Jiang WG (2007) Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer. Ann Surg Oncol 14, 1909-1918 https://doi.org/10.1245/s10434-007-9376-x
- Yu C, Le AT, Yeger H, Perbal B and Alman BA (2003) NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia. J Pathol 201, 609-615 https://doi.org/10.1002/path.1468
- Mason HR, Lake AC, Wubben JE, Nowak RA and Castellot JJ Jr (2004) The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol Hum Reprod 10, 181-187 https://doi.org/10.1093/molehr/gah028
- Dhar G, Mehta S, Banerjee S et al (2007) Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition. Cancer Lett 254, 63-70 https://doi.org/10.1016/j.canlet.2007.02.012
- Kouzu Y, Uzawa K, Kato M et al (2006) WISP-2 expression in human salivary gland tumors. Int J Mol Med 17, 567-573
- Yang Z, Yang Z, Zou Q et al (2014) A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. Int J Clin Oncol 19, 325-335 https://doi.org/10.1007/s10147-013-0550-9
- Tomimaru Y, Koga H, Yano H, de la Monte S, Wands JR and Kim M (2013) Upregulation of T-cell factor-4 isoformresponsive target genes in hepatocellular carcinoma. Liver Int 33, 1100-1112 https://doi.org/10.1111/liv.12188
- Colli LM, Saggioro F, Serafini LN et al(2013) Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors. PLoS One 8, e62424 https://doi.org/10.1371/journal.pone.0062424
- Fritah A, Saucier C, De Wever O et al (2008) Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol 28, 1114-1123 https://doi.org/10.1128/MCB.01335-07
- Banerjee S, Dhar G, Haque I et al (2008) CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer Res 68, 7606-7612\ https://doi.org/10.1158/0008-5472.CAN-08-1461
- Kleer CG, Zhang Y, Pan Q et al (2002) WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 21, 3172-3180 https://doi.org/10.1038/sj.onc.1205462
- Lorenzatti G, Huang W, Pal A, Cabanillas AM and Kleer CG (2011) CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer. J Cell Sci 124, 1752-1758 https://doi.org/10.1242/jcs.084194
- Huang W, Zhang Y, Varambally S et al (2008) Inhibition of CCN6 (Wnt-1-induced signaling protein 3) downregulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Am J Pathol 172, 893-904 https://doi.org/10.2353/ajpath.2008.070899
- Thorstensen L, Diep CB, Meling GI et al (2001) WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology 121, 1275-1280 https://doi.org/10.1053/gast.2001.29570
- Chen CC and Lau LF (2009) Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41, 771-783 https://doi.org/10.1016/j.biocel.2008.07.025
- Lau LF (2011) CCN1/CYR61: the very model of a modern matricellular protein. Cell Mol Life Sci 68, 3149-3163 https://doi.org/10.1007/s00018-011-0778-3
- Abreu JG, Ketpura NI, Reversade B and De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4, 599-604 https://doi.org/10.1038/ncb826
- Nishida T, Kubota S, Aoyama E, Janune D, Maeda A and Takigawa M (2011) Effect of CCN2 on FGF2-induced proliferation and MMP9 and MMP13 productions by chondrocytes. Endocrinology 152, 4232-4241 https://doi.org/10.1210/en.2011-0234
- Li J, Ye L, Owen S, Weeks HP, Zhang Z and Jiang WG (2015) Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). Int J Mol Med 36, 1451-1463 https://doi.org/10.3892/ijmm.2015.2390